A probe test performed 24 h after the final training trial revealed that the untreated APP/PS1 mice exhibited no preference toward the target quadrant, which indicated significant memory impairment, whereas the lentivirus-treated APP/PS1 mice performed similarly to the WT C57BL/6 mice (Figure 6F). Here, APP is linked to memory impairment.